Background: Lack of information about economic burden of COPD is a major cause of lack
of attention to this chronic condition from governments and policymakers. Objective: To find …

Introduction Faced with the challenges of climate change, countries are seeking to
decarbonise their economies. A greater understanding of what comprises the carbon …

There is a substantial burden of chronic respiratory diseases, including chronic obstructive
pulmonary disease (COPD), in low-and middle-income countries (LMICs). LMICs have …

Lung health, the development of lung disease, and how well a person with lung disease is
able to live all depend on a wide range of societal factors. These systemic factors that …

With high prevalence and high burden, the condition we call chronic obstructive pulmonary
disease (COPD) is not so much a respiratory concern as a public-health epidemic [1]. This is …

Introduction Management of chronic obstructive pulmonary disease (COPD) remains a
challenge in primary care and multiple barriers can limit implementation of COPD …

Introduction Maintenance treatment strategies in COPD recommend inhaled corticosteroid
(ICS)+ long-acting muscarinic antagonist (LAMA)+ long-acting β 2-agonist (LABA) triple …

Purpose The changes in grading of disease severity and treatment recommendations for
patients with COPD in the 2017 GOLD strategy may present an opportunity for reducing …

Rationale: Despite awareness of chronic obstructive pulmonary disease (COPD) treatment
recommendations, uptake is poor. The Subpopulations and Intermediate Outcome …

Background This nationwide study was performed to evaluate the evolution of distributions
of patients with COPD according to the 2011 and 2017 Global Initiative for Chronic …